US Biotech Market Analysis

Table of Contents

1. Analyst View

2. Research Overview

3. Industry Overview

• 3.1 Biotechnology Industry Worldwide
• 3.2 US Biotech Industry

4. Industry Performance

• 4.1 Bio Medical
  • 4.1.1 Current Biomedical Business Models
    • 4.1.1.1 Fully Integrated Companies (FICOs: FIPCOs, FIBCOs, FICOPs)
    • 4.1.1.2 Non Research Development Only (NRDOs)
    • 4.1.1.3 Platform Model
    • 4.1.1.4 Mixed Models
    • 4.1.1.5 Medical Device Model
  • 4.1.2 Stages of Growing Biomedical Firm
• 4.2 Agriculture Biotechnology
  • 4.2.1 Production and Economic Impacts
  • 4.2.2 Adoption of Biotechnology Derived Crops
  • 4.2.3 Biotechnology and Biofuels
• 4.3 Clinical Trials
• 4.4 Mergers and Acquisitions
• 4.5 Strategic Alliances
• 4.6 Biotech Funding (Public, Private & Venture Capital)
• 4.7 Biotech Research Parks
  • 4.7.1 Cummings Research Park, Huntsville
  • 4.7.2 ASU (Arizona State University) Research Park
  • 4.7.3 Texas Research Park
  • 4.7.4 Delaware Technology Park
  • 4.7.5 Massachusetts Biotechnology Research Park
  • 4.7.6 UK (University of Kentucky) Coldstream Research Campus
  • 4.7.7 InterTech Science Park
  • 4.7.8 Chicago Technology Park

5. US Bio Cluster

• 5.1 New York
• 5.2 North-West Pennsylvania
• 5.3 Massachusetts
• 5.4 California
• 5.5 Washington

6. Industry Analysis

• 6.1 Key Drivers
  • 6.1.1 Increasing Financing Option
  • 6.1.2 Strong and Stable Biotech Sector
  • 6.1.3 Environmental Drivers
  • 6.1.4 Sociological Drivers
  • 6.1.5 Patent System
  • 6.1.6 Federal Funding
  • 6.1.7 FDA Biopharmaceuticals Approvals
  • 6.1.8 Technology
• 6.2 Opportunities
  • 6.2.1 Opportunity for Developers of Innovative Health Solutions
  • 6.2.2 Biofertilizers/BioPesticides
  • 6.2.3 Agricultural Biotechnology
  • 6.2.4 Biofuel
• 6.3 Challenges
  • 6.3.1 Consumer Preferences & Market Uncertainty
  • 6.3.2 Cost Pressures
  • 6.3.3 Competition from Developing Countries like India & China
  • 6.3.4 Public Acceptance
• 6.4 Future Outlook, 2010

7. Key Players and Company Profiles

• 7.1 Chiron Corporation
• 7.2 Amgen Inc.
• 7.3 Biogen Idec, Inc.
• 7.4 Applied Biosystems
• 7.5 Genentech
• 7.6 Baxter International Inc.

8. Annexure I: Government Initiatives and Regulations

• 8.1 Food and Drug Administration (FDA)
  • 8.1.1 Food
  • 8.1.2 Regulation of Drugs and Biologic Products
• 8.2 United States Department of Agriculture (USDA)
• 8.3 United States Environmental Protection Agency (USEPA)

List of Figures:

• Figure 3-1: Global - Biotechnology Market (in Billion US$), 2001-2005
• Figure 3-2: Global - Biotechnology Market Share by Region (%), 2005
• Figure 3-3: Global - Biotechnology Market Share by Segment (%), 2005
• Figure 3-4: Global - Forecast for Biotechnology Market (in Billion US$), 2006-2010
• Figure 3-5: US - Biotechnology Market (in Billion US$), 2001-2006E
• Figure 3-6: US - Biotechnology Market Share by Segment (%), 2005
• Figure 3-7: US - Distribution Companies by Segment (%), 2005
• Figure 4-1: US - Net Loss Relative to Revenue (%), 1991-2005
• Figure 4-2: US - Employment in Biomedical Sector (%), 2005
• Figure 4-3: US - Interaction among Players in Biomedical and Healthcare Industries
• Figure 4-4: US - Forecast for Clinical Trial Industry (in Billion US$), 2006-2011
• Figure 4-5: US - Clinical Trials (in Numbers), 2003-2006E
• Figure 4-6: US - Forecast for Clinical Trials (in Number), 2007-2011
• Figure 4-7: US - Biotech Financing (in Billion US$), 2004-2006E
• Figure 6-1: US - Biotech Financing (in Billion US$), 2004 & 2005
• Figure 6-2: US - FDA Approvals (in Numbers), 2000 to Jun' 2006
• Figure 6-3: US - Ethanol Demand (in Billion Gallons), 2006-2008E
• Figure 6-4: US - Forecast for Biotech Market (in Billion US$), 2007-2010

List of Tables:

• Table 3-1: Biotechnology Industry Segments and Applications
• Table 4-1: US - Regulatory History of Biomedical Industry
• Table 4-2: US - Stages for Biomedical Companies
• Table 4-3: US - Overall Impact of Biotechnology Derived Crops on Agriculture (2001 & 2003 to 2005)
• Table 4-4: US - Percentage Adoption of Biotechnology Derived Crops (2003-2005)
• Table 4-5: US - Impact of Biotechnology on Crops (Production & Pesticides Reduction), 2005
• Table 4-6: US - Impact of Agricultural Biotechnology on Crops, 2005
• Table 4-7: US - Impact of Bitechnology Corn on Grain and Ethanol Production (1996-2005)
• Table 4-8: US - Selected Biotech M&As (in Million US$), 2005
• Table 4-9: US - Biotech Alliances (in Million US$), 2005
• Table 4-10: US - Biotech Financing (in Million US$), 2004 & 2005
• Table 5-1: Massachusetts - List of FDA Approved Biotechnology Products
• Table 6-1: US - FDA Approvals by Drug Name, Company & Type
• Table 7-1: Amgen Inc. - Key Financials (in Million US$), 2004 to Sep' 2006
• Table 7-2: Biogen Idec, Inc. - Key Financials (in Million US$), 2004 to Sep' 2006
• Table 7-3: Applied Biosystems - Key Financials (in Billion US$), June' 2006
• Table 7-4: Genentech - Key Financials (in Million US$), 2004 to Sep' 2006
• Table 7-5: Baxter International Inc. - Key Financials (in Million US$), 2005 & Sep' 2006
• Table 8-1: US - Federal Biotechnology Regulatory Framework